• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

公共精神卫生机构为同时患有酒精使用障碍的个体提供药物的组织能力和准备情况。

Organizational Capacity and Readiness to Provide Medication for Individuals with Co-Occurring Alcohol Use Disorders in Public Mental Health Settings.

机构信息

RAND Corporation, 1776 Main Street, Santa Monica, CA, 90407, USA.

Department of Family Medicine, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA, 90095, USA.

出版信息

Adm Policy Ment Health. 2021 Jul;48(4):707-717. doi: 10.1007/s10488-020-01103-5. Epub 2021 Jan 2.

DOI:10.1007/s10488-020-01103-5
PMID:33387128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8628547/
Abstract

Alcohol use disorders (AUD) in individuals with mental illness are largely untreated. The purpose of this study was to identify gaps in organizational capacity and readiness to provide medications for AUD in outpatient public mental health clinics. We selected a purposive sample of eight publicly funded outpatient mental health clinics operated by the Los Angeles County Department of Mental Health; clinics were chosen to maximize heterogeneity. Guided by theories of organizational capacity and readiness and research on the adoption of pharmacotherapy for AUD in primary and specialty care treatment settings, we conducted semi-structured interviews and focus groups with administrators, providers and staff, and a qualitative analysis of the results. Respondents described significant organizational capacity and behavioral readiness constraints to providing medication treatment for AUD. Both groups articulated a perception that mental health clinics were not designed to provide co-occurring AUD treatment because of large caseloads, staffing configurations, and time constraints that did not support the delivery of appropriate treatment, and a lack of protocols and workflow procedures. We documented organizational capacity and readiness constraints which impede the delivery of medication treatment for AUD in a large mental helth system. While some constraints have straightforward solutions, others require structural changes to the way care is delivered, and state-level funding and policy changes.

摘要

精神疾病患者中的酒精使用障碍(AUD)大部分未得到治疗。本研究旨在确定组织能力和准备情况方面的差距,以在门诊公共心理健康诊所提供 AUD 的药物治疗。我们选择了洛杉矶县心理健康部运营的八家有公共资金支持的门诊心理健康诊所作为有目的的样本;选择诊所是为了最大限度地提高异质性。在组织能力和准备情况理论以及在初级和专科护理治疗环境中采用 AUD 药物治疗的研究的指导下,我们对管理人员、提供者和工作人员进行了半结构式访谈和焦点小组,并对结果进行了定性分析。受访者描述了在提供 AUD 药物治疗方面存在重大组织能力和行为准备方面的限制。这两个群体都认为,由于大量的病例量、人员配置和时间限制不支持提供适当的治疗,而且缺乏协议和工作流程程序,心理健康诊所的设计不适合提供共病 AUD 治疗。我们记录了在大型心理健康系统中提供 AUD 药物治疗的组织能力和准备情况方面的限制。虽然一些限制有简单的解决方案,但其他限制则需要对护理提供方式进行结构性改变,还需要州一级的资金和政策改变。

相似文献

1
Organizational Capacity and Readiness to Provide Medication for Individuals with Co-Occurring Alcohol Use Disorders in Public Mental Health Settings.公共精神卫生机构为同时患有酒精使用障碍的个体提供药物的组织能力和准备情况。
Adm Policy Ment Health. 2021 Jul;48(4):707-717. doi: 10.1007/s10488-020-01103-5. Epub 2021 Jan 2.
2
Barriers to and Facilitators of Alcohol Use Disorder Pharmacotherapy in Primary Care: A Qualitative Study in Five VA Clinics.初级保健中酒精使用障碍药物治疗的障碍和促进因素:在五家退伍军人事务诊所进行的定性研究。
J Gen Intern Med. 2018 Mar;33(3):258-267. doi: 10.1007/s11606-017-4202-z. Epub 2017 Oct 30.
3
Implementing alcohol use disorder pharmacotherapy in primary care settings: a qualitative analysis of provider-identified barriers and impact on implementation outcomes.在基层医疗环境中实施酒精使用障碍药物治疗:对提供者确定的障碍及其对实施结果的影响的定性分析。
Addict Sci Clin Pract. 2019 Jul 10;14(1):24. doi: 10.1186/s13722-019-0151-7.
4
Attitudes about medications for alcohol use disorder among individuals with serious mental illness: A health belief model analysis.严重精神疾病患者对酒精使用障碍药物治疗的态度:健康信念模型分析
J Subst Abuse Treat. 2020 Jul;114:108007. doi: 10.1016/j.jsat.2020.108007. Epub 2020 Apr 20.
5
Differences in Perceptions of and Practices Regarding Treatment of Alcohol Use Disorders Among VA Primary Care Providers in Urban and Rural Clinics.VA 基层医疗保健提供者在城市和农村诊所中对酒精使用障碍治疗的认知和实践差异。
J Rural Health. 2018 Sep;34(4):359-368. doi: 10.1111/jrh.12293. Epub 2018 Jan 23.
6
Enhancing access to alcohol use disorder pharmacotherapy and treatment in primary care settings: ADaPT-PC.在初级保健机构中增加酒精使用障碍药物治疗和治疗服务的可及性:初级保健酒精使用障碍适应性治疗(ADaPT-PC)
Implement Sci. 2016 May 10;11:64. doi: 10.1186/s13012-016-0431-5.
7
Organizational readiness in specialty mental health care.专科精神卫生保健中的组织准备。
J Gen Intern Med. 2010 Jan;25 Suppl 1(Suppl 1):27-31. doi: 10.1007/s11606-009-1133-3.
8
Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.增加酒精使用障碍药物治疗实施的策略:护理提供和实施干预的系统评价。
Addict Sci Clin Pract. 2019 Feb 12;14(1):6. doi: 10.1186/s13722-019-0134-8.
9
A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation.纵向研究物质使用障碍治疗计划中酒精药物治疗的采用情况:可持续性和停药模式。
J Stud Alcohol Drugs. 2011 Jul;72(4):669-77. doi: 10.15288/jsad.2011.72.669.
10
Integrating Treatment for Co-Occurring Mental Health Conditions.合并出现的心理健康状况的综合治疗
Alcohol Res. 2019 Jan 1;40(1). doi: 10.35946/arcr.v40.1.07. eCollection 2019 Oct 24.

引用本文的文献

1
Advancing healthcare equity through dissemination and implementation science.通过传播和实施科学来促进医疗保健公平。
Health Serv Res. 2023 Dec;58 Suppl 3(Suppl 3):327-344. doi: 10.1111/1475-6773.14175. Epub 2023 May 23.
2
Conceptualizing the Socio-Built Environment: An Expanded Theoretical Framework to Promote a Better Understanding of Risk for Nonmedical Opioid Overdose Outcomes in Urban and Non-Urban Settings.概念化社会-建筑环境:一个扩展的理论框架,以促进更好地理解城市和非城市环境中非医疗类阿片类药物过量结果的风险。
J Urban Health. 2022 Aug;99(4):701-716. doi: 10.1007/s11524-022-00645-3. Epub 2022 Jun 7.
3
Wait No Longer: Reducing Medication Wait-Times for Individuals with Co-Occurring Disorders.等待不再:减少共病患者的药物等待时间。
J Dual Diagn. 2022 Apr-Jun;18(2):101-110. doi: 10.1080/15504263.2022.2052225. Epub 2022 Apr 7.
4
Improving Medication Access within Integrated Treatment for Individuals with Co-Occurring Disorders in Substance Use Treatment Agencies.改善物质使用治疗机构中并发疾病个体综合治疗中的药物可及性。
Implement Res Pract. 2021 Jan 1;2. doi: 10.1177/26334895211033659. Epub 2021 Sep 17.

本文引用的文献

1
Integrated dual diagnosis treatment among United States mental health treatment facilities: 2010 to 2018.美国心理健康治疗机构的综合双重诊断治疗:2010年至2018年
Drug Alcohol Depend. 2020 Aug 1;213:108074. doi: 10.1016/j.drugalcdep.2020.108074. Epub 2020 May 27.
2
Organizational Facilitators and Barriers to Medication for Opioid Use Disorder Capacity Expansion and Use.促进和阻碍阿片类药物使用障碍药物治疗能力扩张和使用的组织因素。
J Behav Health Serv Res. 2020 Oct;47(4):439-448. doi: 10.1007/s11414-020-09706-4.
3
Treatment for Substance Use Disorder With Co-Occurring Mental Illness.共病精神疾病的物质使用障碍治疗
Focus (Am Psychiatr Publ). 2019 Apr;17(2):88-97. doi: 10.1176/appi.focus.20180042. Epub 2019 Apr 10.
4
Caring for patients with co-occurring mental health & substance use disorders.照顾同时患有精神健康和物质使用障碍的患者。
J Fam Pract. 2019 Sep;68(7):400-404.
5
Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT study.评估并提高基层医疗中实施物质使用障碍治疗的组织准备度:来自SUMMIT研究的结果
BMC Fam Pract. 2017 Dec 21;18(1):107. doi: 10.1186/s12875-017-0673-6.
6
Building Capacity for Evidence-Based Public Health: Reconciling the Pulls of Practice and the Push of Research.建设循证公共卫生能力:协调实践的拉力和研究的推力。
Annu Rev Public Health. 2018 Apr 1;39:27-53. doi: 10.1146/annurev-publhealth-040617-014746. Epub 2017 Nov 20.
7
Barriers to integrating the continuum of care for opioid and alcohol use disorders in primary care: A qualitative longitudinal study.将阿片类药物和酒精使用障碍的连续护理纳入初级保健的障碍:一项定性纵向研究。
J Subst Abuse Treat. 2017 Dec;83:45-54. doi: 10.1016/j.jsat.2017.09.015. Epub 2017 Oct 1.
8
Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification.患者对药物的信念与住院阿片类药物脱毒后对美沙酮、丁丙诺啡、纳曲酮或不进行药物辅助治疗的明确偏好相关。
J Subst Abuse Treat. 2016 Jul;66:48-53. doi: 10.1016/j.jsat.2016.02.009. Epub 2016 Mar 9.
9
Counselor training and attitudes toward pharmacotherapies for opioid use disorder.针对阿片类物质使用障碍的药物治疗,咨询师培训及态度
Subst Abus. 2016;37(1):47-53. doi: 10.1080/08897077.2015.1062457. Epub 2015 Jul 13.
10
Comorbid depression and substance abuse among safety-net clients in Los Angeles: a community participatory study.洛杉矶安全网客户中的共病性抑郁症与药物滥用:一项社区参与性研究。
Psychiatr Serv. 2015 Mar 1;66(3):285-94. doi: 10.1176/appi.ps.201300318. Epub 2014 Dec 1.